These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20715848)
1. Thiopalmitoylated peptides from the peripheral nervous system myelin p0 protein: synthesis, characterization, and neuritogenic properties. Beaino W; Trifilieff E Bioconjug Chem; 2010 Aug; 21(8):1439-47. PubMed ID: 20715848 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of palmitoyl-thioester T-cell epitopes of myelin proteolipid protein (PLP). Comparison of two thiol protecting groups (StBu and Mmt) for on-resin acylation. Denis B; Trifilieff E J Pept Sci; 2000 Aug; 6(8):372-7. PubMed ID: 10969866 [TBL] [Abstract][Full Text] [Related]
3. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Linington C; Lassmann H; Ozawa K; Kosin S; Mongan L Eur J Immunol; 1992 Jul; 22(7):1813-7. PubMed ID: 1378018 [TBL] [Abstract][Full Text] [Related]
5. Thiopalmitoylation of altered peptide ligands enhances their protective effects in an animal model of multiple sclerosis. Cloake NC; Beaino W; Trifilieff E; Greer JM J Immunol; 2014 Mar; 192(5):2244-51. PubMed ID: 24489099 [TBL] [Abstract][Full Text] [Related]
6. Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide. Miyamoto K; Miyake S; Schachner M; Yamamura T Eur J Immunol; 2003 Mar; 33(3):656-65. PubMed ID: 12616486 [TBL] [Abstract][Full Text] [Related]
7. P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading. Zhu J; Pelidou SH; Deretzi G; Levi M; Mix E; van der Meide P; Winblad B; Zou LP J Neuroimmunol; 2001 Mar; 114(1-2):99-106. PubMed ID: 11240020 [TBL] [Abstract][Full Text] [Related]
8. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains. Mende F; Beisswenger M; Seitz O J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells. Duan RS; Jin T; Yang X; Mix E; Adem A; Zhu J Glia; 2007 May; 55(7):772-6. PubMed ID: 17357152 [TBL] [Abstract][Full Text] [Related]
11. Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats. Zou LP; Ma DH; Levi M; Wahren B; Wei L; Mix E; van der Meide PH; Link H; Zhu J J Neuroimmunol; 1999 Feb; 94(1-2):109-21. PubMed ID: 10376943 [TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Adelmann M; Linington C Neurochem Res; 1992 Sep; 17(9):887-91. PubMed ID: 1383842 [TBL] [Abstract][Full Text] [Related]
13. Myelin P0 glycoprotein and a synthetic peptide containing the palmitoylation site are both autoacylated. Bharadwaj M; Bizzozero OA J Neurochem; 1995 Oct; 65(4):1805-15. PubMed ID: 7561879 [TBL] [Abstract][Full Text] [Related]
14. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats. Zhu W; Mix E; Jin T; Adem A; Zhu J Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497 [TBL] [Abstract][Full Text] [Related]
15. [Peripheral nerve myelin antigen-specific T cells in human]. Ota K; Shimizu Y; Ueda M; Akiyama N; Iwata M Rinsho Shinkeigaku; 1996 Jul; 36(7):898-901. PubMed ID: 8952362 [TBL] [Abstract][Full Text] [Related]
16. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. Hahn AF Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424 [TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets. de Sèze J; Kremer L; Alves do Rego C; Taleb O; Lam D; Beiano W; Mensah-Nyagan G; Trifilieff E; Brun S Rev Neurol (Paris); 2016 Dec; 172(12):767-769. PubMed ID: 27838091 [TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies to the extracellular domain of P0. Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Linington C; Toyka KV; Hartung HP J Neurosci Res; 1993 May; 35(1):46-53. PubMed ID: 7685397 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN. Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies. Brun S; Beaino W; Kremer L; Taleb O; Mensah-Nyagan AG; Lam CD; Greer JM; de Seze J; Trifilieff E J Neuroimmunol; 2015 Jan; 278():1-10. PubMed ID: 25595246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]